Sy
Synthorx (Sanofi)
La Jolla CAFounded 201450 employees
Private CapbiotechAcquiredOncology
Platform: IL-2 variant
Market Cap
N/A
All Drugs
3
Clinical Trials
8
Failed / Terminated
2
FDA Approved
1
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Doxasertib | SYN-8630 | Preclinical | 1 | AuroraA | UCTTR Amyloidosis | ||
| Doxarasimod | SYN-513 | Phase 3 | 4 | GLP-1R | CTCLCSU | ||
| Zanufotisoran | SYN-6569 | Approved | 3 | BET | CKDADPKD |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (8)